dihydroxyphenylalanine has been researched along with Hakim Syndrome in 2 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Booker, HE | 1 |
| Dahl, DS | 1 |
| Lieberman, AN | 1 |
2 other studies available for dihydroxyphenylalanine and Hakim Syndrome
| Article | Year |
|---|---|
Clinical neurology.
Topics: Basal Ganglia; Cerebrovascular Disorders; Coma; Diagnosis, Differential; Dihydroxyphenylalanine; Hum | 1971 |
Parkinson's disease: a clinical review.
Topics: Adult; Aged; Brain Diseases; Bulbar Palsy, Progressive; Dementia; Diagnosis, Differential; Dihydroxy | 1974 |